74
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Anti-Inflammatory Effect of Novel Analogs of Natural Enkephalinase Inhibitors in a Mouse Model of Experimental Colitis

, , , &
Pages 2231-2243 | Received 30 Jul 2016, Accepted 07 Oct 2016, Published online: 15 Nov 2016

References

  • Sobczak M , SałagaM, StorrMA, FichnaJ. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J. Gastroenterol.49 (1), 24–45 (2014).
  • Leitner GC , VogelsangH. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J. Gastrointest. Pharmacol. Ther.7 (1), 5–20 (2016).
  • Owczarek D , CiborD, MachTet al. Met-enkephalins in patients with inflammatory bowel diseases. Adv. Med. Sci.56 (2), 158–164 (2011).
  • Wisner A , DufourE, MessaoudiMet al. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc. Natl Acad. Sci. USA103 (47), 17979–17984 (2006).
  • Rougeot C , MessaoudiM, HermitteVet al. Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Proc. Natl Acad. Sci. USA100 (14), 8549–8554 (2003).
  • Nishimura K , HazatoT. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem. Biophys. Res. Commun.194, 713–719 (1993).
  • Honda M , OkutsuH, MatsuuraTet al. Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice. Jpn J. Pharmacol.87 (4), 261–267 (2001).
  • Rougeot C , RobertF, MenzL, BissonJF, MessaoudiM. Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects. J. Physiol. Pharmacol.61 (4), 483–490 (2010).
  • Popik P , KamyszE, KreczkoJ, WróbelM. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mouse. Behav. Brain Res.213 (1), 88–93 (2010).
  • Messaoudi M , DesorD, NejdiA, RougeotC. The endogenous androgen-regulated sialorphin modulates male rat sexual behavior. Horm. Behav.46 (5), 684–691 (2004).
  • Liang TS , GaoJL, FatemiO, LavigneM, LetoTL, MurphyPM. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxisby acting as a specific antagonist at the N-formylpeptide receptor subtype FPR. J. Immunol.167, 6609–6614 (2001).
  • Yamamoto Y , KanazawaT, ShimamuraM, UekiM, HazatoT. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2-generation, and exocytosis by N-formylmethionylleucyl-phenylalanine (FMLP)-stimulated neutrophils. Biochem. Pharmacol.54, 695–701 (1997).
  • Thanawala V , KadamVJ, GhoshR. Enkephalins inhibitors: potential agents for the management of pain. Curr. Drug Targets9, 887–895 (2008).
  • Yamamoto Y , OnoH, UedaA, ShimamuraM, NishimuraK, HazatoT. Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation. Curr. Protein Pept. Sci.3 (6), 587–599 (2002).
  • Chan WC , WhitePD. Fmoc Solid Phase Peptide Synthesis. A Practical Approach.Oxford University Press, Oxford, UK (2000).
  • Barlos K , ChatziO, GatosD, StavropoulosG. 2-Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int. J. Pept. Protein Res.37, 513–520 (1991).
  • Perlikowska R , FichnaJ, Claude Do-regoJ, GachK, JaneckaA. Kinetics studies of novel inhibitors of endomorphin degrading enzymes. Med. Chem. Res.21, 1445–1450 (2012).
  • Oefner C , PierauS, SchulzH, DaleGE. Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV. Acta Crystallogr. D Biol. Crystallogr.63 (Pt 9), 975–981 (2007).
  • Letarte M , VeraS, TranRet al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med.168, 1247–1253 (1988).
  • Pearlman DA , CaseDA, CaldwellJWet al. AMBER a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to stimulate the structure and energetic properties of molecules. Comput. Phys. Commun.91, 1–41 (1995).
  • Case DA , CheathamTEIII, DardenTet al. The Amber biomolecular simulation programs. J. Comput. Chem.26 (16), 1668–1688 (2005).
  • Pikora M , GiełdońA. RASMOL AB – new functionalities in the program for structure analysis. Acta Biochim. Pol.62 (3), 629–631 (2015).
  • Wong AH , ZhouD, RiniJM. The x-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing. J. Biol. Chem.287 (44), 36804–36813 (2012).
  • Seli E , SenturkLM, BahtiyarOM, KayisliUA, AriciA. Expression of aminopeptidase N in human endometrium and regulation of its activity by estrogen. Fertil. Steril.75, 1172–1176 (2001).
  • Larkin MA , BlackshieldsG, BrownNP.et al. Clustal W and Clustal X version 2.0. Bioinformatics23, 2947–2948 (2007).
  • The UniProt Consortium . UniProt: a hub for protein information. Nucleic Acids Res.43, D204–D212 (2015).
  • Sałaga M , MokrowieckaA, ZakrzewskiPKet al. Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH). J. Crohns Colitis8, 998–1009 (2014).
  • Sałaga M , PolepallyPR, ZakrzewskiPKet al. Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors. Biochem. Pharmacol.92, 618–626 (2014).
  • Bogeas A , DuFourE, BissonJF, MessaoudiM, RougeotC. Structure–activity relationship study and function-based petidomimetic design of human opiorphin with improved bioavailability property and unaltered analgesic activity. Biochem. Pharmacol.2 (3), 1000122 (2013).
  • Devault A , LazureC, NaultCet al. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J.6 (5), 1317–1322 (1987).
  • Roques BP . Zinc metallopeptidases: active site structure and design of selective and mixed inhibitors: new approaches in the search for analgesics and anti-hypertensives. Biochem. Soc. Trans.21, 678–685 (1993).
  • Le Moual H , DionN, RoquesBP, CrineP, BoileauG. Asp650 is crucial for catalytic activity of neutral endopeptidase 24–11. Eur. J. Biochem.221, 475–480 (1994).
  • Tiraboschi G , JullianN, TheryV, AntonczakS, Fournie-ZaluskiMC, RoquesBP. A three-dimensional construction of the active site (region 507–749) of human neutral endopeptidase (EC.3.4.24.11). Protein Eng.12 (2), 141–149 (1999).
  • Luciani N , Marie-ClaireC, RuffetE, BeaumontA, RoquesBP, Fournié-ZaluskiMC. Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action. Biochemistry37 (2), 686–692 (1998).
  • Luan Y , XuW. The structure and main functions of aminopeptidase N. Curr. Med. Chem.14 (6), 639–647 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.